Competing interests and undergraduate medical education: time for transparency

Editorial

Paul C Hébert et al. CMAJ. 2010.

. 2010 Sep 7;182(12):1279.

doi: 10.1503/cmaj.100605. Epub 2010 May 10.

No abstract available

Comment in

Disclosure: only a first step.
Abi-Jaoude E, Gorman DA. Abi-Jaoude E, et al. CMAJ. 2010 Oct 5;182(14):1546. doi: 10.1503/cmaj.110-2109. CMAJ. 2010. PMID: 20921261 Free PMC article. No abstract available.
Five steps for ruling out coronary artery disease in general practice.
Hudzik B, Szkodzinski J, Polonski L. Hudzik B, et al. CMAJ. 2011 Mar 8;183(4):463. doi: 10.1503/cmaj.111-2021. CMAJ. 2011. PMID: 21398253 Free PMC article. No abstract available.
Canadian faculties of medicine not in denial.
Busing N. Busing N. CMAJ. 2011 Mar 8;183(4):463. doi: 10.1503/cmaj.111-2020. CMAJ. 2011. PMID: 21398254 Free PMC article. No abstract available.

1. Campbell EG, Gruen RL, Mountford J, et al. A national survey of physician–industry relationships. N Engl J Med. 2007;356:1742–50. - PubMed
1. Gagnon M-A, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5:e1. - PMC - PubMed
1. Industry funding of medical education: report of an AAMC task force. Washington (DC): Association of American Medical Colleges; 2008. [(accessed 2010 Apr. 22)]. Available: http://services.aamc.org/publications/showfile.cfm?file=version114.pdf&p....
1. The Patient Protection and Affordable Care Act. Transparency reports and reporting of physician ownership or investment interests. 8. 2010. [(accessed 2010 Apr. 26.)]. H.R. 3590, Sec. 6002. Available: http://democrats.senate.gov/reform/patient-protection-affordable-care-ac....
1. Tichelaar J, Richir MC, Avis HJ, et al. Do medical students copy the drug treatment choices of their teachers or do they think for themselves? Eur J Clin Pharmacol. 2010;66:407–12. - PMC - PubMed